Viewing Study NCT00004806



Ignite Creation Date: 2024-05-05 @ 11:21 AM
Last Modification Date: 2024-10-26 @ 9:04 AM
Study NCT ID: NCT00004806
Status: COMPLETED
Last Update Posted: 2011-03-30
First Post: 2000-02-24

Brief Title: Phase I Study of Liposome-Mediated Gene Transfer in Patients With Cystic Fibrosis
Sponsor: University of Alabama at Birmingham
Organization: University of Alabama at Birmingham

Study Overview

Official Title: None
Status: COMPLETED
Status Verified Date: 2011-03
Last Known Status: None
Delayed Posting: No
If Stopped, Why?: Not Stopped
Has Expanded Access: False
If Expanded Access, NCT#: N/A
Has Expanded Access, NCT# Status: N/A
Acronym: None
Brief Summary: OBJECTIVES

Evaluate the efficacy and safety of lipid-mediated transfer of the cystic fibrosis transmembrane conductance regulator gene to nasal epithelium in patients with cystic fibrosis
Detailed Description: PROTOCOL OUTLINE Cystic fibrosis transmembrane conductance regulator CFTR gene complexed with lipid is administered intranasally to the right inferior turbinate Lipid without CFTR is administered to the left nostril as a control

Cohorts of 3 patients are given successively lower doses of CFTR each dose complexed with 500 micrograms of lipid

Patients are followed at days 2-12 15 and 21 then every 3-4 days for 3 weeks every 2-3 weeks for 10 weeks and every 3 months thereafter

Study Oversight

Has Oversight DMC: None
Is a FDA Regulated Drug?: None
Is a FDA Regulated Device?: None
Is an Unapproved Device?: None
Is a PPSD?: None
Is a US Export?: None
Is an FDA AA801 Violation?: None
Secondary IDs
Secondary ID Type Domain Link
UAB-11983 None None None